TNF and rheumatoid arthritis: In this report we used gene expression profiling on whole blood from 42 RA patients treated with the monoclonal anti-TNF antibodies infliximab or adalimumab to validate previously reported gene expression signatures [19], [21]–[23], [28] for their predictive value in our independent cohort of RA patients treated with anti-TNF.